Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-04

Clinical Trial Update: Study of Efficacy of Ranibizumab in Different Regimens in Patients With Diabetic Macula Edema [Phase 4]

View source ↗

Summary

Phase 4 trial updating efficacy of ranibizumab regimens in diabetic retinopathy with diabetic macular edema completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ranibizumab (ranibizumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Diabetic Retinopathy | Phase 4 | Status: COMPLETED | Results posted: 2019-01-04